Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Krazati

Adagrasib

Open in the dashboard

Part D claims

892

Prescriptions dispensed, refills included

Drug cost

$14,983,347

Paid at the pharmacy, in all

Prescribers

60

With 11 or more claims of it

In 2024, Medicare Part D recorded 892 claims for Krazati (adagrasib) from 60 prescribers, at a total drug cost of $15 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 32 states and territories
Part D claims for Krazati by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
FL 8 134 $2,290,897
CA 8 125 $1,939,879
NY 5 78 $1,203,392
TX 2 46 $907,276
MD 1 36 $623,880
PA 3 35 $527,839
MI 2 32 $536,409
MN 2 31 $539,580
NC 2 27 $497,152
VA 2 25 $367,582
MO 1 24 $400,617
MA 2 24 $491,605
KY 2 24 $448,945
TN 2 24 $383,427
CO 1 17 $311,100
The other 17 states and territories
State Prescribers Claims Drug cost
NV 1 17 $367,320
NE 1 15 $334,292
WV 1 13 $280,035
WA 1 13 $164,192
KS 1 13 $254,980
NH 1 12 $171,036
ND 1 12 $176,902
SC 1 12 $137,358
GA 1 12 $173,132
AL 1 12 $166,562
OH 1 12 $235,066
NJ 1 12 $178,089
IL 1 11 $86,753
AZ 1 11 $215,477
LA 1 11 $92,846
IN 1 11 $229,023
MT 1 11 $250,706

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 7 of 7
Part D claims for Krazati by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Hematology-Oncology 33 478 $8,065,024
Medical Oncology 14 219 $3,739,224
Physician Assistant 2 58 $954,618
Internal Medicine 5 56 $912,162
Nurse Practitioner 4 56 $796,873
Hematology 1 14 $287,338
Hematopoietic Cell Transplantation and Cellular Therapy 1 11 $228,108

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 60 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Jennifer Tseng Hematology-Oncology FL 47 $697,731 None on record
Sarah Sagorsky Physician Assistant MD 36 $623,880 $7,679
Marcelo Vailati Negrao Medical Oncology TX 35 $664,417 None on record
Shihfan Yeh Hematology-Oncology CA 28 $423,575 None on record
Fernando Santini Medical Oncology NY 27 $432,114 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 60 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record